Not available
Quote | Editas Medicine Inc. (NASDAQ:EDIT)
Last: | $5.65 |
---|---|
Change Percent: | -2.69% |
Open: | $5.72 |
Close: | $5.65 |
High: | $5.85 |
Low: | $5.51 |
Volume: | 1,015,171 |
Last Trade Date Time: | 07/26/2024 03:00:00 am |
News | Editas Medicine Inc. (NASDAQ:EDIT)
2024-07-23 19:32:16 ET Summary Sangamo Therapeutics, Inc. is almost out of cash, and as such, at risk of bankruptcy. Therefore, investing in this company is not a good idea for most investors. 3 of its assets have updates coming over the next 1–6 months that could rea...
2024-07-17 11:30:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Gene-editing stocks are a promising investment because the field is steadily advancing in the areas of medicine and biotechnology. Examples include CRISPR and other gene-editing technologie...
Message Board Posts | Editas Medicine Inc. (NASDAQ:EDIT)
Subject | By | Source | When |
---|---|---|---|
Could be upcoming https://annualmeeting.asgct.org/program/agenda-details?agendaI | jondoeuk | investorshub | 04/13/2023 10:21:36 PM |
Does this have any FDA approvals? | jondoeuk | investorshub | 03/19/2023 7:39:22 PM |
Does this have any FDA approvals? Will Precision | rtrstock | investorshub | 03/07/2023 6:59:07 PM |
PR https://www.globenewswire.com/news-release/2022/05/18/2445810/0/en/Editas-Med | jondoeuk | investorshub | 05/19/2022 5:39:30 PM |
1106: $EDIT-202, a Multiplexed CRISPR-Cas12a Gene-Edited iPSC-Derived NK | jondoeuk | investorshub | 05/02/2022 9:43:49 PM |
News, Short Squeeze, Breakout and More Instantly...